- $354.93m
- $344.82m
- $13.55m
Annual cashflow statement for CapsoVision, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -11.3 | -19.9 | -25.3 |
| Depreciation | |||
| Non-Cash Items | 0.201 | 0.582 | 1.05 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.161 | -0.981 | 1.19 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | -10.8 | -20.1 | -22.9 |
| Capital Expenditures | -0.754 | -0.153 | -0.09 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.754 | -0.153 | -0.09 |
| Financing Cash Flow Items | — | — | -3.18 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 20.5 | 15.1 | 23.6 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 9.01 | -5.24 | 0.793 |